Effect of Quercetin on PCOS patients
Not Applicable
Recruiting
- Conditions
- Poly Cystic Ovary Syndrome.
- Registration Number
- IRCT20210516051323N1
- Lead Sponsor
- Islamic Azad University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 42
Inclusion Criteria
Infertility with documented PCOS & Hyperandrogenism;20-37Y/O; Candidate for IVF Cycle; If have male factor; it must mild to moderate form, not non-obstructive azospermia; If have other female factor; only cervical & tubal factors are acceptable.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Inflamatory factors TNfAlpha, IL6. Timepoint: Before consumption and after puncture surgery. Method of measurement: Elaysa Test on blood sample.
- Secondary Outcome Measures
Name Time Method Effects on expression of Nrf2-Keap1 genes. Timepoint: After puncture surgery. Method of measurement: Real Time PCR Device records.;Protein expression, Keap-1. Timepoint: After the intervention. Method of measurement: western blot.